Atlas Trials

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease

Clinical trial NCT05364684 · COMPLETED

Trial details

NCT number
NCT05364684
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
NAFLDNonalcoholic Fatty LiverNASH - Nonalcoholic Steatohepatitis
Start date
2022-08-10
Primary completion
2024-11-22
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.